News from decision resources A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 22, 2014, 13:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The Canadian Interventional Cardiology Device Market Will Remain Relatively Stagnant Through 2022 at Around $80 Million

 Decision Resources Group finds that the market for interventional cardiology (IC) devices in Canada will remain relatively stagnant at a value...

Jul 22, 2014, 12:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted

 Decision Resources Group finds that over half of audited multiple sclerosis (MS) patients currently treated with Biogen Idec's oral...

Jul 21, 2014, 12:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The Alzheimer's Disease Market Is Forecast to Reach Nearly $12 Billion by 2023, Following the Projected Launch of the First Disease-Modifying Therapies

Decision Resources Group finds that the market for Alzheimer's disease (AD) therapies will more than triple, reaching nearly $12 billion by 2023,...

Jul 21, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Amgen's Evolocumab is Set to Become the Clinical Gold-Standard Among Statin Add-On Therapies for Dyslipidemia

 Decision Resources Group finds that Amgen's evolocumab (AMG-145) is set to become the clinical gold-standard among statin add-on therapies...

Jul 17, 2014, 13:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Physicians to Pharmas: Provide Patient Services or Face Irrelevance

 Decision Resources Group's new Manhattan Research study, ePharma Physician® 2014, indicates that physicians are looking to pharmaceutical...

Jul 17, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Despite Declining Prices, the BRIC Cardiac Rhythm Management Device Market Will Reach $1.6 Billion by 2022

 Decision Resources Group finds that the cardiac rhythm management (CRM) device market in Brazil, Russia, India and China (BRIC) will grow to...

Jul 16, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Multinational Companies Face Protectionist Hurdles as Turkey Lays Plans to Become a Net Exporter of Pharmaceuticals

 Decision Resources Group finds that Turkey continues to hold appeal for multinational pharmaceutical companies due to its large domestic...

Jul 15, 2014, 12:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The High Cost of Second-Generation TKIs for CML is an Obstacle to Effective Reimbursement and Patient Access at the National and Institutional Level in Both Brazil and Mexico

Decision Resources Group finds that, despite the fact that the treatment armamentarium for chronic myeloid leukemia (CML) in Brazil and Mexico...

Jul 15, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The Hepatitis C Virus Drug-Treated Population in the G7 Markets Will Reach Nearly Half a Million Cases in 2016

 Decision Resources Group finds that the hepatitis C virus (HCV) population is large with more than 2 million diagnosed, chronically infected...

Jul 14, 2014, 13:17 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Digital Resources Play Critical Role in Formulary Decision Making

A new Manhattan Research study, Taking the Pulse ® Formulary Decision Makers 2014, finds that members of pharmacy and therapeutics (P&T)...

Jul 14, 2014, 10:30 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Breakthrough Therapy Designation is Likely to Sway Oncologists' Confidence in An Agent and Encourage Prescribing

Decision Resources Group finds that breakthrough therapy designation is likely to positively influence perceptions of emerging drugs for both...

Jul 10, 2014, 15:11 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Shifts In Healthcare Coverage For Millions Of American Lives Create Unique Data Challenge For Next Year Planning

 Decision Resources Group expects American lives to continue their vast migration to coverage, as post-ACA implementation coincides with a...

Jul 10, 2014, 13:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis

Decision Resources Group finds that over half of surveyed nephrologists report awareness of the U.S. Food and Drug Administration's (FDA) approval...

Jul 10, 2014, 11:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT)

 Decision Resources Group finds that while more than three-quarters of surveyed infectious disease (ID) specialists are willing to prescribe...

Jul 09, 2014, 13:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Asia Pacific Interventional Cardiology Device Market Will Continue to Grow Strongly Through 2022, Especially in China and India

 Decision Resources Group finds that the market for interventional cardiology (IC) devices still holds considerable potential for growth in the...

Jul 09, 2014, 11:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Decision Resources Group Announces Enhanced Medical Device Market Coverage with Analysis of U.S. Hospital Purchasing Records and SKU-Level Data Visualized in Tableau

 Decision Resources Group announces the launch of PriceTrack, which is an extension of its premier medical technology market intelligence...

Jul 08, 2014, 12:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Latin American Trauma Device and Reconstructive Joint Implant Market Will Grow to $1.75 Billion by 2022

Decision Resources Group finds that the market for trauma devices and reconstructive joint implants in Argentina, Brazil, Colombia and Mexico will...

Jul 07, 2014, 11:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Growing Concern over the Efficacy of Vancomycin is Prompting Greater Use of Branded Therapies for the Treatment of MRSA Infections

 Decision Resources Group finds that, although vancomycin continues to be the standard-of-care for infections caused by methicillin-resistant...

Jul 07, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Novo Nordisk's Insulin Degludec/Liraglutide is Set to Become the Clinical Gold-Standard Among Fixed-Dose Combination Therapies for Type 2 Diabetes

 Decision Resources Group finds that Novo Nordisk's fixed-dose combination (FDC) therapy insulin degludec/liraglutide (Xultophy, formerly known...

Jul 02, 2014, 13:45 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Medicaid Expansion "Dominoes" Continue To Fall As More States Enact And Submit Waivers

 Decision Resources Group expects most states to move toward Medicaid expansion in the next few years. Two key factors continue to drive the...